{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:44Z","timestamp":1707524984013},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,25]]},"DOI":"10.7759\/cureus.34177","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T08:52:46Z","timestamp":1674636766000},"source":"Crossref","is-referenced-by-count":0,"title":["Domiciliary High-Flow Nasal Therapy in Primary Ciliary Dyskinesia"],"prefix":"10.7759","author":[{"given":"Rita","family":"Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Queir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00facia","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Telma","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30374-1","article-title":"Primary ciliary dyskinesia in the genomics age","volume":"8","author":"Lucas JS","year":"2020","unstructured":"Lucas JS, Davis SD, Omran H, Shoemark A. Primary ciliary dyskinesia in the genomics age. Lancet Respir Med. 2020, 8:202-16. 10.1016\/S2213-2600(19)30374-1","journal-title":"Lancet Respir Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.11.040","article-title":"Understanding primary ciliary dyskinesia and other ciliopathies","volume":"230","author":"Horani A","year":"2021","unstructured":"Horani A, Ferkol TW. Understanding primary ciliary dyskinesia and other ciliopathies. J Pediatr. 2021, 230:15-22.e1. 10.1016\/j.jpeds.2020.11.040","journal-title":"J Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189834","article-title":"Current and future treatments in primary ciliary dyskinesia","volume":"22","author":"Paff T","year":"2021","unstructured":"Paff T, Omran H, Nielsen KG, Haarman EG. Current and future treatments in primary ciliary dyskinesia. Int J Mol Sci. 2021, 22:10.3390\/ijms22189834","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/000348949710601008","article-title":"Incidence of primary ciliary dyskinesia in children with recurrent respiratory diseases","volume":"106","author":"Chapelin C","year":"1997","unstructured":"Chapelin C, Coste A, Reinert P, Boucherat M, Millepied MC, Poron F, Escudier E. Incidence of primary ciliary dyskinesia in children with recurrent respiratory diseases. Ann Otol Rhinol Laryngol. 1997, 106:854-8. 10.1177\/000348949710601008","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2021.11.008","article-title":"Diagnosis of primary ciliary dyskinesia","volume":"43","author":"Goutaki M","year":"2022","unstructured":"Goutaki M, Shoemark A. Diagnosis of primary ciliary dyskinesia. Clin Chest Med. 2022, 43:127-40. 10.1016\/j.ccm.2021.11.008","journal-title":"Clin Chest Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031936","article-title":"The RSPH4A gene in primary ciliary dyskinesia","volume":"24","author":"Jes\u00fas-Rojas W","year":"2023","unstructured":"Jes\u00fas-Rojas W, Mel\u00e9ndez-Monta\u00f1ez J, Mu\u00f1iz-Hern\u00e1ndez J, et al.. The RSPH4A gene in primary ciliary dyskinesia. Int J Mol Sci. 2023, 24:1936. 10.3390\/ijms24031936","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.02.006","article-title":"Clinical and genetic spectrum of children with primary ciliary dyskinesia in China","volume":"159","author":"Guan Y","year":"2021","unstructured":"Guan Y, Yang H, Yao X, et al.. Clinical and genetic spectrum of children with primary ciliary dyskinesia in China. Chest. 2021, 159:1768-81. 10.1016\/j.chest.2021.02.006","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9059","article-title":"Identification of a CCDC114 variant in a Han-Chinese patient with situs inversus","volume":"20","author":"Chen X","year":"2020","unstructured":"Chen X, Deng S, Xia H, Yuan L, Xu H, Tang S, Deng H. Identification of a CCDC114 variant in a Han-Chinese patient with situs inversus. Exp Ther Med. 2020, 20:3336-42. 10.3892\/etm.2020.9059","journal-title":"Exp Ther Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.09.016","article-title":"Nasal high flow therapy for symptom management in people receiving palliative care","volume":"63","author":"Huang JY","year":"2022","unstructured":"Huang JY, Steele P, Dabscheck E, Smallwood N. Nasal high flow therapy for symptom management in people receiving palliative care. J Pain Symptom Manage. 2022, 63:e237-45. 10.1016\/j.jpainsymman.2021.09.016","journal-title":"J Pain Symptom Manage"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00711-2020","article-title":"The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis","volume":"7","author":"Good WR","year":"2021","unstructured":"Good WR, Garrett J, Hockey HU, Jayaram L, Wong C, Rea H. The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis. ERJ Open Res. 2021, 7:10.1183\/23120541.00711-2020","journal-title":"ERJ Open Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1479972307087190","article-title":"Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis","volume":"5","author":"Hasani A","year":"2008","unstructured":"Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis. 2008, 5:81-6. 10.1177\/1479972307087190","journal-title":"Chron Respir Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227221","article-title":"Domiciliary high-flow treatment in patients with COPD and chronic hypoxic failure: in whom can we reduce exacerbations and hospitalizations?","volume":"14","author":"Weinreich UM","year":"2019","unstructured":"Weinreich UM. Domiciliary high-flow treatment in patients with COPD and chronic hypoxic failure: in whom can we reduce exacerbations and hospitalizations?. PLoS One. 2019, 14:e0227221. 10.1371\/journal.pone.0227221","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.12.016","article-title":"The clinical utility of long-term humidification therapy in chronic airway disease","volume":"104","author":"Rea H","year":"2010","unstructured":"Rea H, McAuley S, Jayaram L, et al.. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010, 104:525-33. 10.1016\/j.rmed.2009.12.016","journal-title":"Respir Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-4546-9_4","article-title":"Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure","volume":"755","author":"Nilius G","year":"2013","unstructured":"Nilius G, Franke KJ, Domanski U, R\u00fchle KH, Kirkness JP, Schneider H. Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure. Adv Exp Med Biol. 2013, 755:27-34. 10.1007\/978-94-007-4546-9_4","journal-title":"Adv Exp Med Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207962","article-title":"Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial","volume":"71","author":"Fraser JF","year":"2016","unstructured":"Fraser JF, Spooner AJ, Dunster KR, Anstey CM, Corley A. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax. 2016, 71:759-61. 10.1136\/thoraxjnl-2015-207962","journal-title":"Thorax"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.4.1108","article-title":"The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease","volume":"126","author":"Chatila W","year":"2004","unstructured":"Chatila W, Nugent T, Vance G, Gaughan J, Criner GJ. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest. 2004, 126:1108-15. 10.1378\/chest.126.4.1108","journal-title":"Chest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S159666","article-title":"Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure","volume":"13","author":"Storgaard LH","year":"2018","unstructured":"Storgaard LH, Hockey HU, Laursen BS, Weinreich UM. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018, 13:1195-205. 10.2147\/COPD.S159666","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2019.09.009","article-title":"High-flow nasal cannula versus conventional oxygen therapy in relieving dyspnea in emergency palliative patients with do-not-intubate status: a randomized crossover study","volume":"75","author":"Ruangsomboon O","year":"2020","unstructured":"Ruangsomboon O, Dorongthom T, Chakorn T, et al.. High-flow nasal cannula versus conventional oxygen therapy in relieving dyspnea in emergency palliative patients with do-not-intubate status: a randomized crossover study. Ann Emerg Med. 2020, 75:615-26. 10.1016\/j.annemergmed.2019.09.009","journal-title":"Ann Emerg Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/133082-domiciliary-high-flow-nasal-therapy-in-primary-ciliary-dyskinesia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:57Z","timestamp":1707508137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/133082-domiciliary-high-flow-nasal-therapy-in-primary-ciliary-dyskinesia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.34177","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,25]]}}}